Weight management and current options in pharmacotherapy: orlistat and sibutramine.
about
Treating morbid obesity in cirrhosis: A quest of holy grailVaccination against GIP for the treatment of obesitySafety profile of orlistat: results of a prescription-event monitoring study.Evaluation of 8-week body weight control program including sea tangle (Laminaria japonica) supplementation in Korean female college students.Childhood Obesity: Review of a growing Problem.Obesity in children & adolescentsAMPK as Target for Intervention in Childhood and Adolescent ObesitySibutramine-associated adverse effects: a practical guide for its safe use.Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns.Physical activity as the main therapeutic tool for metabolic syndrome in childhood.Vascular disease: obesity and excess weight as modulators of risk.Anti-obesity drugs: a review about their effects and their safety.Investigational glucagon-like peptide-1 agonists for the treatment of obesity.A study of the use of drugs in the treatment of obesity among adult females.Comparison of orlistat treatment and placebo in obese type 2 diabetic patients.Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.Effect of orlistat on cardiovascular disease risk in obese adults.Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification?Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes.Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients.Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice.Potential lipase inhibitors from Chinese medicinal herbs.
P2860
Q26775811-B56A6B78-EDF0-43B6-B68D-E7461657EEDBQ27300376-45C42BA7-1D3C-4524-BCB3-973E3DE7CE90Q33434964-F7323D8B-87C3-4366-86C3-B1AC703C1833Q33602007-78D555DD-3ECE-4BAD-9B91-004C0DB08963Q34140141-9DBF7483-7484-4805-953A-20BE98F63765Q34530149-2CEC2D51-D9A9-444F-B625-262D745109C8Q34557477-10D08EE3-ADA5-4683-8D4C-FEAAF6E2A164Q34585304-9EBDB6D2-76ED-4627-8F47-73488EFAA9FFQ37359377-DC8A498E-9F56-4FB8-AF66-697FC95452FFQ37817710-CE1B59E3-F12D-4C0D-A200-4D7CBF72B5D4Q37868586-8B33C9A0-DE15-4812-9BE7-87FE0D1DD4ECQ37996099-ED3130E8-83A4-4E17-AC07-B784E16A91E5Q38937735-E986350A-4B9E-4EED-9D83-BACEA50DB47CQ38997091-1918E11F-59A8-4924-B57A-1F9CC4BD38D6Q43009560-93ACF628-1E9C-4ECD-A1C6-FA36604E3897Q45218155-3324C9E2-6C6E-4059-9049-8E93CAAD7732Q46422669-9133E3AB-8C53-42A8-A40E-79366C3E89CCQ47303022-45C93905-0D0C-454B-85B2-8F7CBBAB066EQ47332159-D00AFEB3-7305-4A6C-9725-F7A201FB563DQ51369967-E8ADB996-3D90-4CB7-9F1E-CBA752D0AD50Q51386908-08258593-5312-45F1-82B6-53F9BDC3C71CQ51599856-61887DC8-7FC9-4CA1-ADAC-9A32FB03E78BQ54380640-0292DBA7-E81C-4AB8-ABEC-FDFC76BC9897
P2860
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@ast
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@en
type
label
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@ast
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@en
prefLabel
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@ast
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@en
P2093
P1476
Weight management and current options in pharmacotherapy: orlistat and sibutramine.
@en
P2093
Brian Tomlinson
G Neil Thomas
Juliana C N Chan
Wilson Y S Leung
P356
10.1016/S0149-2918(03)90009-9
P577
2003-01-01T00:00:00Z